Reduce Sugar Intake Several studies suggest higher consumption of refined sugar, particularly fructose and sugar-sweetened sodas, increases urine and serum uric acid levels and kidney stone risk (Ferraro 2013
Regenerative Medicine & Scar Treatments Membership Program: Unlock Exclusive Benefits Join our Biohacking Beyond Beauty Membership for only $149 per month and enjoy a range of exclusive benefits: Custom Wellness Check : Kickstart your journey with our comprehensive wellness check, which includes a comprehensive consultation and initial labs to evaluate your health status

Cycling and Duration: Long-Term Ideal Dose and Dosing for Tesamorelin/Ipamorelin Blend Standard Cycling Protocols Cycling prevents receptor desensitization and maintains long-term effectiveness: Protocol 1: Standard Cycle On-cycle : 12 weeks at therapeutic dose Off-cycle : 4 weeks complete break Repeat : 2-3 cycles per year Protocol 2: Extended Cycle On-cycle : 16-20 weeks at therapeutic dose Off-cycle : 6-8 weeks complete break Repeat : 2 cycles per year Protocol 3: Pulse Cycling Week 1-3 : Full therapeutic dose Week 4 : 50% dose reduction Repeat : Continuous with periodic dose reductions Weekly Dosing Schedules The 5-days-on, 2-days-off approach is most common: Example Schedule: Monday: Inject Tuesday: Inject Wednesday: Inject Thursday: Inject Friday: Inject Saturday: Rest Sunday: Rest Alternative schedules include: 6 days on, 1 day off : For more aggressive protocols Alternating days : Every other day dosing (less common with this blend) Signs It's Time to Cycle Off Monitor these indicators that suggest cycling off is appropriate : Diminishing returns on body composition changes Increased water retention or joint discomfort Sleep disruption or excessive fatigue Elevated fasting glucose or insulin resistance markers Loss of appetite or digestive issues Numbness or tingling in extremities Taking strategic breaks allows receptors to resensitize and maintains the peptide's effectiveness over years of use

however, this is not currently listed as a class contraindication in UK Summaries of Product Characteristics (SmPCs) for licensed GLP-1 receptor agonists, and patients should not assume a blanket prohibition applies
Retrieved from Feier, C.V.I., Vonica, R.C., Faur, A.M., et al
Patients can get $20 off when you refer a friend